Literature DB >> 15160547

Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis.

Elisabeth C Samouilidou1, Eirini J Grapsa, Ioannis Kakavas, Antonios Lagouranis, Basilis Agrogiannis.   

Abstract

OBJECTIVE: The inflammatory status is a well-documented factor influencing the development of oxidative stress in dialysis patients. This study intends to evaluate the inflammatory activity and the plasma levels of total antioxidant capacity (TAC) and lipid peroxidation products in patients on peritoneal dialysis (PD), by comparison with hemodialysis (HD) patients. PATIENTS AND METHODS: Plasma concentration of TAC, lipid peroxidation products and C-reactive protein (CRP) were measured in 24 patients on PD, 32 HD patients (pre and post treatment) and 16 normal controls (NC).
RESULTS: All patients had higher levels of TAC and lipid peroxidation products than NC (p < 0.001). Patients on PD, had similar levels to patients before HD but significantly higher (p < 0.001) than those post HD. The CRP concentration was higher in HD than in PD patients (p < 0.05). The percentage of patients with CRP > 10 mg/l was 48% in HD patients and 21% in PD patients. No correlation was observed between CRP and TAC nor CRP and MDA levels.
CONCLUSIONS: We conclude that although PD and HD patients show an equal susceptibility in oxidative stress, CRP levels are higher in HD patients and this is indicative of a higher degree of inflammatory activity in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15160547     DOI: 10.1023/b:urol.0000022846.83505.3f

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

Review 1.  C-reactive protein, inflammation, and coronary risk.

Authors:  D A Morrow; P M Ridker
Journal:  Med Clin North Am       Date:  2000-01       Impact factor: 5.456

2.  Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis.

Authors:  C Fiorillo; C Oliviero; G Rizzuti; C Nediani; A Pacini; P Nassi
Journal:  Clin Chem Lab Med       Date:  1998-03       Impact factor: 3.694

3.  Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment.

Authors:  T Nguyen-Khoa; Z A Massy; J P De Bandt ; M Kebede; L Salama; G Lambrey; V Witko-Sarsat; T B Drüeke; B Lacour; M Thévenin
Journal:  Nephrol Dial Transplant       Date:  2001-02       Impact factor: 5.992

4.  Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy.

Authors:  M Haubitz; R Brunkhorst; E Wrenger; P Froese; M Schulze; K M Koch
Journal:  Perit Dial Int       Date:  1996 Mar-Apr       Impact factor: 1.756

5.  Oxidative stress and inflammation in hemodialysis patients.

Authors:  M A Spittle; N A Hoenich; G J Handelman; R Adhikarla; P Homel; N W Levin
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

6.  A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates.

Authors:  N J Miller; C Rice-Evans; M J Davies; V Gopinathan; A Milner
Journal:  Clin Sci (Lond)       Date:  1993-04       Impact factor: 6.124

Review 7.  An overview of haemodialysis and oxidant stress.

Authors:  C Tetta; S Biasioli; R Schiavon; P Inguaggiato; S David; V Panichi; M L Wratten
Journal:  Blood Purif       Date:  1999       Impact factor: 2.614

8.  Reduced oxidative stress in hypoalbuminemic CAPD patients.

Authors:  S B Kim; W S Yang; W K Min; S K Lee; J S Park
Journal:  Perit Dial Int       Date:  2000 May-Jun       Impact factor: 1.756

9.  Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.

Authors:  C McIntyre; I Harper; I C Macdougall; A E Raine; A Williams; L R Baker
Journal:  Clin Nephrol       Date:  1997-12       Impact factor: 0.975

10.  Increased lipid peroxidation in patients on maintenance hemodialysis.

Authors:  A Dasgupta; S Hussain; S Ahmad
Journal:  Nephron       Date:  1992       Impact factor: 2.847

View more
  13 in total

Review 1.  Coronary artery disease and nuclear imaging in renal failure.

Authors:  Tochi Okwuosa; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

2.  Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease.

Authors:  Paolo Ferrari; Hemant Kulkarni; Shyam Dheda; Susanne Betti; Colin Harrison; Timothy G St Pierre; John K Olynyk
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

3.  Associations between serum hepcidin level, FGF-21 level and oxidative stress with arterial stiffness in CAPD patients.

Authors:  Sena Memnune Ulu; Seref Yuksel; Atila Altuntaş; Emre Kacar; Ahmet Ahsen; Abdullah Altug; Sefa Celik; M Tugrul Sezer
Journal:  Int Urol Nephrol       Date:  2014-06-08       Impact factor: 2.370

4.  Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.

Authors:  Kuang-Wei Huang; Hsin-Bang Leu; Jiing-Chyuan Luo; Wan-Leong Chan; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Yi-Chun Kuan
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

5.  Gastrointestinal bleeding in patients with renal failure under hemodialysis treatment: a single-center experience.

Authors:  Özgür Can; Gözde Koç; Sema Berk Ocak; Nursel Akbay; Emel Ahishali; Mustafa Canbakan; Gülizar Manga Şahin; Süheyla Apaydin
Journal:  Int Urol Nephrol       Date:  2017-01-25       Impact factor: 2.370

6.  The potential effects of pomegranate (Punica granatum) juice on carbon tetrachloride-induced nephrotoxicity in rats.

Authors:  Ahmed E Abdel Moneim; Manal F El-Khadragy
Journal:  J Physiol Biochem       Date:  2012-11-07       Impact factor: 4.158

7.  Green Tea Attenuates Oxidative Stress and Downregulates the Expression of Angiotensin II AT(1) Receptor in Renal and Hepatic Tissues of Streptozotocin-Induced Diabetic Rats.

Authors:  Martha Thomson; Khaled Al-Qattan; Mohamed H Mansour; Muslim Ali
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-14       Impact factor: 2.629

8.  Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study.

Authors:  Enas A Hamed; Taghrid B El-Abaseri; Amany O Mohamed; Ahmed R Ahmed; Tarek H El-Metwally
Journal:  BMC Nephrol       Date:  2012-10-13       Impact factor: 2.388

9.  Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia.

Authors:  Ingrid Wiswedel; Daniela Peter; Andreas Gardemann; Francesco Carluccio; Hannelore Hampl; Werner Siems
Journal:  Biomark Insights       Date:  2008-05-27

10.  Comparison of plasma oxidative biomarkers and conformational modifications of hemoglobin in patients with diabetes on hemodialysis.

Authors:  Hadi Ansarihadipour; Hamidreza Dorostkar
Journal:  Iran Red Crescent Med J       Date:  2014-11-11       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.